Fingerprint
Dive into the research topics of 'Phase I study of dose-escalated busulfan with fludarabine and alemtuzumab as conditioning for allogeneic hematopoietic stem cell transplant: Reduced clearance at high doses and occurrence of late sinusoidal obstruction syndrome/veno-occlusive disease'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically